Where do you study? http://imagefap.in.net/ fap images Naloxegol is a peripherally-acting mu-opioid receptor antagonist (PAMORA) was licensed from Nektar Therapeutics in September 2009. Under the terms of the agreement, the latter will receive a $70 million milestone payment once the NDA is accepted by the FDA.
